DAX20.642 -5,0%ESt504.878 -4,6%Top 10 Crypto11,23 +2,3%Dow38.315 -5,5%Nas15.588 -5,8%Bitcoin75.726 -1,0%Euro1,0961 ±-0,0%Öl66,06 -5,4%Gold3.038 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Tesla A1CX3T Rheinmetall 703000 NVIDIA 918422 Apple 865985 Amazon 906866 Allianz 840400 Mercedes-Benz Group (ex Daimler) 710000 RENK RENK73 Lufthansa 823212 Infineon 623100 Microsoft 870747 BASF BASF11 Deutsche Bank 514000 Volkswagen (VW) vz. 766403 Nike 866993
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
US-Zölle: China schlägt zurück -- DAX geht massiv tiefer ins Wochenende -- Wall Street stürzt letztlich ab -- Aktien von Rheinmetall, RENK & HENSOLDT im Minus -- Novo Nordisk, Apple im Fokus
Top News
Branchenrotation - Durch Branchenkenntnis Überrenditen erzielen Branchenrotation - Durch Branchenkenntnis Überrenditen erzielen
Bitcoin, Dogecoin, Ethereum & Co. am Nachmittag Bitcoin, Dogecoin, Ethereum & Co. am Nachmittag
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Bis zu 3,05 % Zinsen: Jetzt die besten Tagesgeld-Angebote checken

Quest Diagnostics Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
149,65 EUR -5,05 EUR -3,26 %
STU
164,17 USD -6,45 USD -3,78 %
nachbörslich
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.16,62 Mrd. EUR

KGV19,69Div. Rendite1,99%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN904533

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS74834L1008

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolDGX

Quest Diagnostics Aktien News

DatumMeistgelesen
PR NewswireQuest Diagnostics Declares Quarterly Cash Dividend
PR NewswireWorkforce Drug Test Cheating Surged in 2023, Finds Quest Diagnostics Drug Testing Index Analysis of Nearly 10 Million Drug Tests
PR NewswireQuest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference
PR NewswireQuest Diagnostics Names Murali Balakumar Senior Vice President and Chief Information and Digital Officer
PR NewswireQuest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI
PR NewswireQuest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024
PR NewswireQuest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease
PR NewswireQuest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay
PR NewswireQuest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024
PR NewswireQuest Diagnostics to Speak at the Barclays 26th Annual Global Healthcare Conference
PR NewswireQuest Diagnostics and Instacart Collaborate to Reduce Food Insecurity Across the United States with Integrated Patient Health Coaching and Nutritious Grocery Delivery
PR NewswireFreenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
PR NewswireQuest Diagnostics Debuts MelaNodal Predict™ Test, Personalizing Melanoma Risk Prediction to Help Patients Forgo Invasive Surgery
PR NewswireFirst PFAS "Forever Chemicals" Consumer-Initiated Blood Test with Physician Consult Launches on questhealth.com
PR NewswireQuest Diagnostics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Guidance for Full Year 2024; Increases Quarterly Dividend 5.6% to $0.75 Per Share
PR NewswireTen Years Running: FORTUNE Names Quest Diagnostics one of 2024 "World's Most Admired Companies"
PR NewswireHaystack Oncology, developer of Haystack MRD™, and TriSalus Life Sciences collaborate in connection with the clinical development of TriSalus' TLR9 agonist in hepatocellular carcinoma, intrahepati...
PR NewswireQuest Diagnostics to Release Fourth Quarter and Full Year 2023 Financial Results on February 1, 2024
PR NewswireFitbit and Quest Diagnostics Collaborate to Advance Research on the Use of Wearable Devices to Improve Metabolic Health
PR NewswireQuest Diagnostics Acquires Select Assets of Outreach Lab Services Business of Steward Health Care System
PR NewswireHaystack Oncology and Alliance Foundation Trials collaborate to use Haystack MRD™ technology in phase II clinical trial for unresectable stage III NSCLC
PR NewswireQuest Diagnostics to Speak at the 42nd Annual J.P. Morgan Healthcare Conference
PR NewswireQuest Diagnostics Names Yuri A. Fesko, M.D., Senior Vice President and Chief Medical Officer
PR NewswireQuest Diagnostics Launches New 88-Compound Novel Psychoactive Substance Test Panel
PR NewswireHaystack Oncology and Rutgers Cancer Institute Collaborate to use Haystack MRD™ in Clinical Study of Early-Stage Triple-Negative Breast Cancer
PR NewswireQuest Diagnostics and CDC Expand Public Health Research Collaboration to Better Understand Hepatitis C Burden in the United States
PR NewswireQuest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid Arthritis
PR NewswireUniversal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States
MyDividendsQuest Diagnostics wird eine unveränderte Dividende auszahlen
PR NewswireQuest Diagnostics Declares Quarterly Cash Dividend
PR NewswireQuest Diagnostics Launches Mobile Phlebotomy Service, Enabling Convenient At-Home Specimen Collection in the United States
PR NewswireDiadem SpA Announces Exclusive U.S. Licensing Agreement with Quest Diagnostics for Its AlzoSure® Predict Alzheimer's Disease Prognostic Technology
PR NewswireQuest Diagnostics Reports Third Quarter 2023 Financial Results; Updates Guidance for Full Year 2023
PR NewswireNeway Forms Lab Services Agreement with Quest Diagnostics to Speed Quality ESRD Testing
PR NewswireQuest Diagnostics to Release Third Quarter 2023 Financial Results on October 24, 2023
PR NewswireQuest Diagnostics to Speak at the Baird 2023 Global Healthcare Conference
PR NewswireQuest Diagnostics Releases 2022 Corporate Responsibility Report
PR NewswireQuest Diagnostics Granted FDA Breakthrough Designation for its Adeno-associated virus (AAV) Test
MyDividendsQuest Diagnostics hält die Dividende stabil
PR NewswireQuest Diagnostics Declares Quarterly Cash Dividend
Wer­bung

Quest Diagnostics News

Quest Diagnostics News: auf dieser Seite finden Sie alle Quest Diagnostics News und Nachrichten zur Quest Diagnostics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Quest Diagnostics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Quest Diagnostics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.